Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Analysis: Understanding The Drivers Behind 8.7% CAGR Through 2030 Growth
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Set To Climb From $3.23 Billion In 2026 To $4.51 Billion By 2030
The catheter-associated urinary tract infection (CAUTI) prevention urology products market has experienced robust expansion in recent years. It is projected to increase from $2.98 billion in 2025 to $3.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.4%. This historical growth can be attributed to several factors, including the increasing incidence of catheter-associated urinary tract infections, a growing patient population within hospitals and long-term care facilities, the widespread adoption of infection control protocols, heightened awareness of urinary hygiene, and the expansion of urology-focused medical devices.
The market for catheter-associated urinary tract infection (CAUTI) prevention urology products is projected to experience robust expansion over the coming years. This market is set to reach $4.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This projected growth is driven by several factors, including the increasing acceptance of antimicrobial and intelligent catheters, greater integration with patient monitoring systems, an uptick in demand within home care environments, the proliferation of minimally invasive urology procedures, and a heightened emphasis on regulatory adherence and preventing infections. Key trends anticipated during this period encompass the growing use of antimicrobial urinary catheters, an increased need for closed system intermittent catheters, the broader integration of catheter securement devices, the availability of advanced smart foley catheters equipped with monitoring capabilities, and an elevated focus on catheter solutions for both home care and long-term care settings.
Get A Free Sample Report With In-Depth Market Insights:
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Development Factors: What’s Supporting Demand?
An anticipated increase in hospital-acquired infection rates is projected to drive expansion within the catheter-associated urinary tract infection (CAUTI) prevention urology products market. Hospital-acquired infection rates quantify how often patients contract infections while hospitalized, distinct from conditions present upon their admission. A major contributor to the increase in these infection rates is antimicrobial resistance, enabling pathogens to withstand typical treatments and facilitate their dissemination within healthcare environments. Products for preventing catheter-associated urinary tract infection (CAUTI) contribute to lowering hospital-acquired infection rates through their action of reducing bacterial colonization and biofilm development on indwelling catheters, consequently diminishing the likelihood of urinary tract infections among hospitalized individuals. For example, data from May 2024, supplied by the US-based disease research organization, the Center for Infectious Disease Research and Policy (CIDRAP), indicated that approximately 4.3 million patients annually acquired at least one healthcare-acquired infection in hospitals throughout the European Union and European Economic Area during 2022 and 2023. Consequently, the escalating hospital-acquired infection rates are a key impetus for the expansion of the catheter-associated urinary tract infection (CAUTI) prevention urology products market.
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Segments: Where Is Growth Concentrated?
The catheter-associated urinary tract infection (CAUTI) prevention urology products market covered in this report is segmented –
1) By Product Type: Antimicrobial Urinary Catheters, Intermittent Catheters, Foley Catheters, Catheter Securement Devices, Urine Collection Bags
2) By Material Type: Silicone, Latex, Hydrogel Coated, Silver Alloy Coated
3) By Application Outlook: Urinary Incontinence Management, Acute Surgical Perioperative Care, Benign Prostatic Hyperplasia And Obstructive Urology, Neurogenic Bladder And Spinal Cord Injury, Other Applications
4) By End Use Outlook: Hospitals, Long Term Care Facilities, Home Care Setting, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Antimicrobial Urinary Catheters: Silver Alloy Coated Urinary Catheters, Nitrofurazone Impregnated Urinary Catheters, Antibiotic Coated Urinary Catheters, Hydrophilic Coated Antimicrobial Urinary Catheters, Antiseptic Coated Urinary Catheters
2) By Intermittent Catheters: Hydrophilic Intermittent Catheters, Pre Lubricated Intermittent Catheters, Closed System Intermittent Catheters, Uncoated Intermittent Catheters, Single Use Sterile Intermittent Catheters
3) By Foley Catheters: Two Way Foley Catheters, Three Way Foley Catheters, Silicone Foley Catheters, Latex Foley Catheters, Temperature Sensing Foley Catheters
4) By Catheter Securement Devices: Adhesive Anchor Securement Devices, Leg Strap Securement Devices, Stat Lock Securement Devices, Stabilization Platform Devices, Adjustable Catheter Securement Systems
5) By Urine Collection Bags: Leg Mounted Urine Collection Bags, Bedside Drainage Urine Collection Bags, Closed System Drainage Bags, Anti Reflux Valve Urine Collection Bags, Graduated Measurement Urine Collection Bags
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Transformation Trends: What Innovations Are Driving Change?
Leading companies operating within the catheter associated urinary tract infection (CAUTI) prevention urology products market are concentrating on developing innovative solutions, such as female external catheter devices, to enhance patient comfort, decrease infection risk, and improve overall urinary care outcomes. A female external catheter device represents a non-invasive medical apparatus worn externally over the female genital area to safely and comfortably collect urine, thereby assisting in managing urinary incontinence and reducing the potential for infection. For example, in January 2026, Wellspect HealthCare, a Sweden based medical device company, introduced the Surity Female External Catheter, an innovative non-invasive product for urinary incontinence management that supports women experiencing severe urinary incontinence and their caregivers. It is engineered for easy placement, helps prevent leakage, protects skin integrity, and supports extended overnight use while integrating with compatible urine collection systems, addressing a notable gap in continence care where few options have existed. Its design prioritizes comfort, reliability, and predictable daily use in both home and healthcare settings as a modern alternative to indwelling catheters.
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Competitive Overview And Top Companies
Major companies operating in the catheter-associated urinary tract infection (CAUTI) prevention urology products market are Cardinal Health Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Becton, Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Nipro Corporation, Coloplast A/S, Teleflex Incorporated, Cook Medical LLC, ConvaTec Group PLC, Hollister Incorporated, Merit Medical Systems Inc., Amsino International Inc., Laborie Medical Technologies Inc., Cathetrix Inc., Bactiguard AB, Poiesis Medical Inc.
View The Full Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Report:
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Urology Products Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the catheter-associated urinary tract infection (CAUTI) prevention urology products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the catheter-associated urinary tract infection (CAUTI) prevention urology products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.